Search Results 5551-5560 of 17080 for mesenteric fat and ibd

1. Efficacy and Safety Trial of MK-8931 in Participants With Prodromal Alzheimer's Disease (MK-8931-019) - Mayo Clinic

   The purpose of this trial is to assess the efficacy and safety of MK-8931 compared with placebo in the treatment of amnestic mild cognitive impairment (aMCI) ...

2. Dupilumab Treatment on Sinonasal Respiratory Symptoms and Sense of Smell in Ethnically Diverse Patients with Chronic Rhinosinusitis and Nasal Polyps - Mayo Clinic

   The purpose of this study is to to identify pathways by which dupilumab may “normalize” the immune response in patients with Chronic Rhinosinusitis and Nasal ...

3. A Study to Evaluate Exercise and Hypoxic Responses to Isovolemic Hemodilution in Rare Hemoglobin Variant Humans - Mayo Clinic

   The goal of this study is to determine how oxygen binding to reduced levels of hemoglobin affects the acute responses to oxygen delivery in exercising muscle in ...

4. Genomic Assessment of Patients With Severe Radiation Reactions - Mayo Clinic

   About this study. Determine an underlying etiology behind unexpectedly severe reactions to radiation by blood draw. Participation eligibility.

5. An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered via Transendocardial Catheter-based Injections to Subjects with Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM) - Mayo Clinic

   An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered via Transendocardial Catheter-based Injections to Subjects with Heart Failure Due to ...

6. A Study of Novel Biomarkers in Suspected Cardiogenic Shock - Mayo Clinic

   The purpose of this study is to assess biomarkers of Cardiogenic Shock (CS) which may be associated with the development of and outcomes after CS to provide ...

7. A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous Malformations - Mayo Clinic

   A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous ...

8. Defibrotide for Patients with Hepatic Veno-occlusive Disease: A Treatment IND Study - Mayo Clinic

   Single arm, open-label study to provide Defibrotide to patients diagnosed with VOD. Defibrotide is no longer available though the Emergency Use IND mechanism ( ...

9. Safety Study of Mocetinostat in Combination With Azacitidine in Subjects With MDS - Mayo Clinic

   Mocetinostat is an orally administered histone deacetylase (HDAC) inhibitor. Azacitidine is a hypomethylating agent (HMA) used to treat MDS. In this study, ...

10. A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors - Mayo Clinic

    Phase 2 only: To assess preliminary antitumor activity by overall response rate (ORR) as measured by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 ...